Search Results - "ZISSEL, G"

Refine Results
  1. 1

    Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis by Chaudhary, N. I, Roth, G. J, Hilberg, F, Muller-Quernheim, J, Prasse, A, Zissel, G, Schnapp, A, Park, J. E

    Published in The European respiratory journal (01-05-2007)
    “…BIBF 1000 is a small molecule inhibitor targeting the receptor kinases of platelet-derived growth factor (PDGF), basic fibroblast growth factor and vascular…”
    Get full text
    Journal Article
  2. 2

    The value of bronchoalveolar lavage for discrimination between healthy and diseased individuals by Frye, B. C., Schupp, J. C., Rothe, M. E., Köhler, T. C., Prasse, A., Zissel, G., Vach, W., Müller‐Quernheim, J.

    Published in Journal of internal medicine (01-01-2020)
    “…Background Bronchoalveolar lavage (BAL) is standard diagnostic procedure. Procedural recommendations have been made by pneumological societies including normal…”
    Get full text
    Journal Article
  3. 3

    A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18 by Prasse, Antje, Pechkovsky, Dmitri V, Toews, Galen B, Jungraithmayr, Wolfgang, Kollert, Florian, Goldmann, Torsten, Vollmer, Ekkehard, Muller-Quernheim, Joachim, Zissel, Gernot

    “…Recently, models of macrophage activation have been revised. Macrophages stimulated with Th2 cytokines have been classified as alternatively activated. This…”
    Get full text
    Journal Article
  4. 4

    Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients by Muller-Quernheim, J, Gaede, K. I, Fireman, E, Zissel, G

    Published in The European respiratory journal (01-06-2006)
    “…An increase in chronic beryllium disease (CBD) has been suggested due to higher industrial use of beryllium alloys. Since occupational CBD is a perfect…”
    Get full text
    Journal Article
  5. 5

    Genotype-corrected reference values for serum angiotensin-converting enzyme by Biller, H, Zissel, G, Ruprecht, B, Nauck, M, Busse Grawitz, A, Muller-Quernheim, J

    Published in The European respiratory journal (01-12-2006)
    “…The deletion (D)/insertion (I) polymorphism in intron 16 of the angiotensin-converting enzyme (ACE) gene has the greatest impact on serum ACE level in…”
    Get full text
    Journal Article
  6. 6

    New Pathogenetic Concepts and Early Pharmacological Studies in Sarcoidosis by Schupp, J C, Frye, B C, Zissel, G, Müller-Quernheim, J

    Published in Pneumologie (Stuttgart, Germany) (01-04-2016)
    “…The etiology of sarcoidosis is still elusive, yet there has been considerable progress in various areas of basic and clinical research. This review focuses on…”
    Get more information
    Journal Article
  7. 7

    Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis by FEHRENBACH, H, ZISSEL, G, GOLDMANN, T, TSCHERNIG, T, VOLLMER, E, PABST, R, MÜLLER-QUERNHEIM, J

    Published in The European respiratory journal (01-03-2003)
    “…Tumour necrosis factor (TNF)-alpha is known to play a major role in the formation of noncaseating granuloma, a hallmark of sarcoidosis. The main cellular…”
    Get full text
    Journal Article
  8. 8

    Interleukin-13 acts as an apoptotic effector on lung epithelial cells and induces pro-fibrotic gene expression in lung fibroblasts by Borowski, A., Kuepper, M., Horn, U., Knüpfer, U., Zissel, G., Höhne, K., Luttmann, W., Krause, S., Virchow Jr, J. C., Friedrich, K.

    Published in Clinical and experimental allergy (01-04-2008)
    “…Summary Background IL‐13 promotes acute allergic asthma and is discussed to play a role in late asthmatic features such as fibrotic processes and airway…”
    Get full text
    Journal Article
  9. 9

    Generation and evaluation of a monoclonal antibody, designated MAdL, as a new specific marker for adenocarcinomas of the lung by Schultz, H, Marwitz, S, Baron-Lühr, B, Zissel, G, Kugler, C, Rabe, K F, Zabel, P, Vollmer, E, Gerdes, J, Goldmann, T

    Published in British journal of cancer (23-08-2011)
    “…Background: Different therapy regimens in non-small-cell lung cancer (NSCLC) are of rising clinical importance, and therefore a clear-cut subdifferentiation is…”
    Get full text
    Journal Article
  10. 10

    Local administration of uridine suppresses the cardinal features of asthmatic airway inflammation by Müller, T., Grimm, M., De Vieira, R. P., Cicko, S., Dürk, T., Sorichter, S., Zissel, G., Idzko, M.

    Published in Clinical and experimental allergy (01-10-2010)
    “…Summary Background The immuno‐modulatory properties of nucleotides such as adenosine or inosine, have been described extensively. Recently, the nucleoside…”
    Get full text
    Journal Article
  11. 11

    Gene polymorphisms of ACE and the angiotensin receptor AT2R1 influence serum ACE levels in sarcoidosis by Biller, H, Ruprecht, B, Gaede, K I, Müller-Quernheim, J, Zissel, G

    “…Angiotensin converting enzyme (ACE) is thought to influence susceptibility, disease progression, and/or outcome of sarcoidosis by functional…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Pattern of NOS2 and NOS3 mRNA expression in human A549 cells and primary cultured AEC II by Pechkovsky, D V, Zissel, G, Goldmann, T, Einhaus, M, Taube, C, Magnussen, H, Schlaak, M, Müller-Quernheim, J

    “…The human alveolar type II epithelium-like cell line A549 expresses nitric oxide synthase type 2 (NOS2), but not NOS3, and produces nitric oxide (NO) upon…”
    Get more information
    Journal Article
  14. 14

    Human alveolar epithelial cells induce nitric oxide synthase-2 expression in alveolar macrophages by Pechkovsky, D.V, Zissel, G, Stamme, C, Goldmann, T, Ari Jaffe, H, Einhaus, M, Taube, C, Magnussen, H, Schlaak, M, Muller-Quernheim, J

    Published in The European respiratory journal (01-04-2002)
    “…It was hypothesized that cell-to-cell interaction between human alveolar macrophages (AM) and alveolar epithelium, might be an important factor leading to…”
    Get full text
    Journal Article
  15. 15

    Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis by Zissel, G, Homolka, J, Schlaak, J, Schlaak, M, Müller-Quernheim, J

    “…Sarcoidosis is a systemic, granulomatous disorder with a high rate of spontaneous remission indicating the presence of antiinflammatory mechanisms…”
    Get more information
    Journal Article
  16. 16

    Th1/Th2 cell distribution in pulmonary sarcoidosis by Bäumer, I, Zissel, G, Schlaak, M, Müller-Quernheim, J

    “…Cytokines released by T lymphocytes activated in the course of sarcoidosis, e.g., interleukin-2 (IL-2) and interferon-gamma (IFN-gamma), indicate the presence…”
    Get more information
    Journal Article
  17. 17

    Analysis of the Kveim-Siltzbach test reagent for bacterial DNA by RICHTER, E, KATARIA, Y. P, ZISSEL, G, HOMOLKA, J, SCHLAAK, M, MULLER-QUERNHEIM, J

    “…The sarcoid spleen-derived reagent for the Kveim-Siltzbach test (KST) elicits a sarcoid-specific, granulomatous, cutaneous response used to establish the…”
    Get full text
    Journal Article
  18. 18

    Assessment of transcriptional gene activity in situ by application of HOPE-fixed, paraffin-embedded tissues by Goldmann, T, Wiedorn, K H, Kühl, H, Olert, J, Branscheid, D, Pechkovsky, D, Zissel, G, Galle, J, Müller-Quernheim, J, Vollmer, E

    Published in Pathology, research and practice (2002)
    “…We report the use of HOPE-fixation (HOPE = Hepes-Glutamic acid buffer mediated Organic solvent Protection Effect) for specimens utilized for in situ…”
    Get full text
    Journal Article
  19. 19
  20. 20

    (1229) Fibroblast Activation Protein Alpha (fapa) in Chronic Lung Allograft Dysfunction by Moneke, I., Burkle, J., Pfaffendorf, E., Bronsert, P., Zissel, G., Faendrich, S., Passlick, B., Diederichs, S., Jungraithmayr, W.

    “…Chronic lung allograft dysfunction (CLAD) limits survival after lung transplantation (Tx). CLAD is characterized by a progressive fibrosis within small airways…”
    Get full text
    Journal Article